Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.

Uutela M, Lindholm J, Louhivuori V, Wei H, Louhivuori LM, Pertovaara A, Akerman K, Castrén E, Castrén ML.

Genes Brain Behav. 2012 Jul;11(5):513-23. doi: 10.1111/j.1601-183X.2012.00784.x. Epub 2012 Apr 11.

2.

BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.

Louhivuori V, Vicario A, Uutela M, Rantamäki T, Louhivuori LM, Castrén E, Tongiorgi E, Akerman KE, Castrén ML.

Neurobiol Dis. 2011 Feb;41(2):469-80. doi: 10.1016/j.nbd.2010.10.018. Epub 2010 Nov 1.

PMID:
21047554
3.

Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.

Spencer CM, Serysheva E, Yuva-Paylor LA, Oostra BA, Nelson DL, Paylor R.

Hum Mol Genet. 2006 Jun 15;15(12):1984-94. Epub 2006 May 4.

4.

Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments.

Baker KB, Wray SP, Ritter R, Mason S, Lanthorn TH, Savelieva KV.

Genes Brain Behav. 2010 Aug;9(6):562-74. doi: 10.1111/j.1601-183X.2010.00585.x. Epub 2010 Apr 6.

5.

Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.

Brennan FX, Albeck DS, Paylor R.

Genes Brain Behav. 2006 Aug;5(6):467-71.

6.

The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Olmos-Serrano JL, Corbin JG, Burns MP.

Dev Neurosci. 2011;33(5):395-403. doi: 10.1159/000332884. Epub 2011 Nov 8.

7.

Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice.

Gorski JA, Balogh SA, Wehner JM, Jones KR.

Neuroscience. 2003;121(2):341-54.

PMID:
14521993
8.

Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of fragile X syndrome.

Yang Q, Feng B, Zhang K, Guo YY, Liu SB, Wu YM, Li XQ, Zhao MG.

PLoS Genet. 2012;8(12):e1003172. doi: 10.1371/journal.pgen.1003172. Epub 2012 Dec 27.

9.

Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.

Dansie LE, Phommahaxay K, Okusanya AG, Uwadia J, Huang M, Rotschafer SE, Razak KA, Ethell DW, Ethell IM.

Neuroscience. 2013 Aug 29;246:186-98. doi: 10.1016/j.neuroscience.2013.04.058. Epub 2013 May 7.

10.

BDNF in fragile X syndrome.

Castrén ML, Castrén E.

Neuropharmacology. 2014 Jan;76 Pt C:729-36. doi: 10.1016/j.neuropharm.2013.05.018. Epub 2013 May 29. Review.

PMID:
23727436
11.

Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice.

Real MA, Simón MP, Heredia R, de Diego Y, Guirado S.

J Comp Neurol. 2011 Sep 1;519(13):2622-36. doi: 10.1002/cne.22643.

PMID:
21491426
12.

Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.

Frankland PW, Wang Y, Rosner B, Shimizu T, Balleine BW, Dykens EM, Ornitz EM, Silva AJ.

Mol Psychiatry. 2004 Apr;9(4):417-25.

PMID:
14981523
13.

Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.

Michalon A, Bruns A, Risterucci C, Honer M, Ballard TM, Ozmen L, Jaeschke G, Wettstein JG, von Kienlin M, Künnecke B, Lindemann L.

Biol Psychiatry. 2014 Feb 1;75(3):189-97. doi: 10.1016/j.biopsych.2013.05.038. Epub 2013 Jul 30.

PMID:
23910948
14.

Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome.

Nielsen DM, Derber WJ, McClellan DA, Crnic LS.

Brain Res. 2002 Feb 8;927(1):8-17.

PMID:
11814427
15.

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.

Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ.

PLoS One. 2011;6(10):e26203. doi: 10.1371/journal.pone.0026203. Epub 2011 Oct 12.

16.

BDNF regulates the expression of fragile X mental retardation protein mRNA in the hippocampus.

Castrén M, Lampinen KE, Miettinen R, Koponen E, Sipola I, Bakker CE, Oostra BA, Castrén E.

Neurobiol Dis. 2002 Oct;11(1):221-9.

PMID:
12460560
17.

Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.

Goebel-Goody SM, Wilson-Wallis ED, Royston S, Tagliatela SM, Naegele JR, Lombroso PJ.

Genes Brain Behav. 2012 Jul;11(5):586-600. doi: 10.1111/j.1601-183X.2012.00781.x. Epub 2012 Apr 6.

18.

Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background.

Ding Q, Sethna F, Wang H.

Behav Brain Res. 2014 Sep 1;271:72-8. doi: 10.1016/j.bbr.2014.05.046. Epub 2014 Jun 2.

19.

Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.

Amiri A, Sanchez-Ortiz E, Cho W, Birnbaum SG, Xu J, McKay RM, Parada LF.

Autism Res. 2014 Feb;7(1):60-71. doi: 10.1002/aur.1342. Epub 2014 Jan 9.

PMID:
24408886
20.

Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.

Zeier Z, Kumar A, Bodhinathan K, Feller JA, Foster TC, Bloom DC.

Gene Ther. 2009 Sep;16(9):1122-9. doi: 10.1038/gt.2009.83. Epub 2009 Jul 2.

Items per page

Supplemental Content

Write to the Help Desk